Clinical trial evaluating the safety, tolerability, and preliminary efficacy of BNT116 alone and in combinations in patients with advanced non-small cell lung cancer
BNT116-01
Phase 1 other active
Quick answer
Clinical trial evaluating the safety, tolerability, and preliminary efficacy of BNT116 alone and in combinations in patients with advanced non-small cell lung cancer for Advanced non-small cell lung cancer is a Phase 1 program (other) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Advanced non-small cell lung cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active